Volume | 1,190,655 |
|
|||||
News | - | ||||||
Day High | 0.24 | Low High |
|||||
Day Low | 0.2167 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Matinas Biopharma Holdings Inc | MTNB | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.24 | 0.2167 | 0.24 | 0.24 | 0.23 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,109 | 1,190,655 | $ 0.2261972 | $ 269,323 | - | 0.1103 - 0.89 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
20:00:00 | 53,231 | $ 0.24 | USD |
Matinas Biopharma Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
52.14M | 217.26M | - | 3.19M | -21M | -0.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Matinas Biopharma News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MTNB Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.21 | 0.24 | 0.2001 | 0.2137091 | 991,878 | 0.0263 | 12.52% |
1 Month | 0.2996 | 0.3056 | 0.2001 | 0.2276183 | 1,545,381 | -0.0633 | -21.13% |
3 Months | 0.1591 | 0.89 | 0.1172 | 0.4924644 | 9,813,628 | 0.0772 | 48.52% |
6 Months | 0.3874 | 0.89 | 0.1103 | 0.4761941 | 4,945,400 | -0.1511 | -39.0% |
1 Year | 0.62 | 0.89 | 0.1103 | 0.4800753 | 2,707,012 | -0.3837 | -61.89% |
3 Years | 1.20 | 2.22 | 0.1103 | 0.8493691 | 2,005,017 | -0.9637 | -80.31% |
5 Years | 0.7984 | 2.49 | 0.1103 | 0.9190685 | 1,862,949 | -0.5621 | -70.4% |
Matinas Biopharma Description
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. |